Medical Science News

RSS

Study identifies new allergy pathway

Researchers at Johns Hopkins Bloomberg School of Public Health have identified the sequence of molecular events by which tiny, tick-like creatures called house dust mites trigger asthma and allergic rhinitis.

25 Jun 2020

GW researchers awarded $2.2 million to study chronic stress

The National Institutes of Health has awarded $2.2 million to researchers at the George Washington University School of Medicine and Health Sciences for a study on chronic stress.

25 Jun 2020

New Cochrane review assesses the accuracy of COVID-19 antibody tests

Today Cochrane, a global independent organization that reviews evidence from research to inform health decision-making, publishes a review of studies looking at the accuracy of COVID-19 antibody tests.

25 Jun 2020

Superbug hijacks the wound healing system to cause serious and persistent disease

Monash University researchers have discovered that the devastating bacterial superbug Clostridioides difficile hijacks the human wound healing system in order to cause serious and persistent disease, opening up the development of new therapies to treat the disease.

25 Jun 2020

Research team profiles the body's immune response to COVID-19

A team from Lawson Health Research Institute and Western University are the first in the world to profile the body's immune response to COVID-19.

25 Jun 2020

Common food additive alters gut microbiota in mice

A common food additive, recently banned in France but allowed in the U.S. and many other countries, was found to significantly alter gut microbiota in mice, causing inflammation in the colon and changes in protein expression in the liver, according to research led by a University of Massachusetts Amherst food scientist.

25 Jun 2020

Variation in natural speech is challenging for dyslexic adults

A new study brings neural-level evidence that the continuous variation in natural speech makes the discrimination of phonemes challenging for adults suffering from developmental reading-deficit dyslexia.

25 Jun 2020

G6PD enzyme offers a promising therapeutic target in autoimmune diseases

A team from the University of Valencia, the La Fe Hospital Health Research Institute, and the INCLIVA Institute have participated in the identification of an enzyme (G6PD) as a possible therapeutic target in autoimmune diseases or in controlling exacerbated inflammatory responses such as the one caused by SARS-CoV-2 infection.

25 Jun 2020

Researchers develop gold nanoparticles to reduce neuronal cell death

Gold nanoparticles have been developed in the laboratory in order to reduce the cell death of neurons exposed to overexcitement.

25 Jun 2020

A metabolic enzyme drives B cell lymphomas and could be a potential drug target

Scientists at the Sloan Kettering Institute have found that increased activity of a normal metabolic enzyme can lead to cancer. The enzyme, SHMT2, is a driver of a large portion of B cell lymphomas and could be a potential drug target.

24 Jun 2020

Short-term exposure to low level air pollution can affect gene expression

New data from a landmark study by Monash University researchers raises concerns that even short-term exposure to low level air pollution can affect gene expression, leaving us at risk of diseases such as cancer, cardiovascular and respiratory diseases.

24 Jun 2020

Tau protein modifications may be linked to heterogeneity in Alzheimer’s disease

A new study reveals a possible biological reason that Alzheimer's Disease (AD) progresses at different rates in different patients.

24 Jun 2020

Researchers develop a noninvasive technology to destroy cancer cells

An international research team led by Dr. Tali Ilovitsh of the Biomedical Engineering Department at Tel Aviv University developed a noninvasive technology platform for gene delivery into breast cancer cells.

24 Jun 2020

Transgenic rice containing anti-hypertensive peptides lowers blood pressure in hypertensive rats

In the future, taking your blood pressure medication could be as simple as eating a spoonful of rice.

24 Jun 2020

Neuroscientists shed new light on mechanisms responsible for familial migraine

Neuroscientists of the University of Zurich shed a new light on the mechanisms responsible for familial migraine: They show that a genetic dysfunction in specific brain cells of the cingulate cortex area strongly influences head pain occurrence.

24 Jun 2020

Researchers report a key breakthrough to help protect newborns from brain damage

Oxygen deprivation can be the worst start to a newborn's life, resulting in brain damage, epilepsy, developmental delays and death.

23 Jun 2020

Problems in how the brain recognizes and processes novel information underlie psychosis

Problems in how the brain recognizes and processes novel information lie at the root of psychosis, researchers from the University of Cambridge and King's College London have found.

23 Jun 2020

Bioactive factors-imprinted scaffold vehicles for boosting bone repair

Announcing a new article publication for BIO Integration journal. In this review article the authors Peng-Peng Xue, Jian-dong Yuan, Qing Yao, Ying-Zheng Zhao and He-Lin Xu, from Wenzhou Medical University, Wenzhou City, China consider bioactive factors-imprinted scaffold vehicles for promoting bone healing.

23 Jun 2020

Dana-Farber CEO Emeritus wins 2020 ASH Award for Leadership in Promoting Diversity

Edward J. Benz, Jr., MD, President and CEO Emeritus of the Dana-Farber Cancer Institute and the Richard and Susan Smith Distinguished Professor at Harvard Medical School, has received the 2020 ASH Award for Leadership in Promoting Diversity.

23 Jun 2020

Discovery provides a potential target for infectious diseases immunotherapy

NIH investigators and colleagues have discovered that when the immune system first responds to infectious agents such as viruses or bacteria, a natural brake on the response prevents overactivation.

23 Jun 2020